Keraderm's technology uses germicidal light to prevent and treat infections and disorders. Our technology provides a platform to develop a wide range of treatments for skin and nail infections and disorders such as psoriasis.

Research shows that our proprietary treatment is significantly superior to traditional germicidal ultraviolet light treatment. Germicidal ultraviolet light is particularly effective at inactivating undesirable organisms. Keraderm's enhanced treatment uses this wavelength and adds other synergistic wavelengths which greatly increase treatment efficacy.

Keraderm has obtained comprehensive patent protection on key aspects of its proprietary technology. Keraderm has also filed a number of additional provisional and non-provisional applications on further enhancements and applications of its technology.

Clinical trials have shown that our treatment is efficacious and has a very low occurrence of side effects. The data compare very favorably with treatments that are currently on the market. We believe our treatment can effectively treat a wide variety of skin and nail infections and disorders.